Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer

JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
Anticancer Research December 2018, 38 (12) 6789-6795; DOI: https://doi.org/10.21873/anticanres.13050
JASMINE M. MANOUCHEHRI
1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
2Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, OH, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL KALAFATIS
1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
2Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, OH, U.S.A.
3Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation Cleveland, OH, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.kalafatis{at}csuohio.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    UA augmented apoptosis induced by rhTRAIL in TNBCs. TNBC cells treated with UA with and without 100 ng/ml rhTRAIL over a 72-h period. (A) The displayed plots obtained from FACS analysis, Annexin V−/PI+-dead cells are depicted in the left top quadrants, Annexin V−/PI−-viable cells are depicted in the left bottom quadrants, Annexin V+/PI−-early apoptotic cells are depicted in the right bottom quadrants, and Annexin V+/PI+-late apoptotic, dead cells are depicted in the right top quadrants. Bar graphs (B) BT-20 and (C) HCC1937 illustrate the mean total percentage of apoptotic cells (Annexin V+ cells)±SEM derived from three independent experiments performed in triplicate (n=9). * represents p<0.05.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    UA and rhTRAIL facilitate apoptosis by the extrinsic pathway. Co-treated TNBC (A) BT-20 and (B) HCC1937 cells were sensitized to rhTRAIL-induced apoptosis, as demonstrated by caspase 8 activation, caspase 3 activation, and PARP cleavage.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    UA-treated cells' expression of DR4 and DR5. Protein levels of DR4 and DR5 (mature form) were determined in (A) BT-20 cells and (B) HCC1937; UA boosted DR4 and DR5 expression in TNBCs following 72 h of treatment in a dose-dependent manner. (C) Protein levels of DR4 and DR5 (mature form) were examined in UA-treated MCF-10A cells, and expression of DRs was not changed. Flow cytometry analysis of cell surface expression of DR4 and DR5 in (D) BT-20 and (E) HCC1937 cells treated with UA; the bar graphs illustrate the mean fold increase in the cell surface expressions of DR4 or DR5 relative to the vehicle-treated control ±SEM from three independent experiments performed in triplicate (n=9). * represents p<0.05.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    UA transcriptionally controls c-FLIPL down-regulation and DRs up-regulation. (A) Western blot analysis showing that UA decreased the expression of c-FLIPL in TNBC cells in a dose-dependent manner. (B) RT-PCR was executed with β-actin as a positive control in UA-treated (72 h) BT-20 and HCC1937 cells. UA diminished c-FLIPL mRNA expression in TNBC cells and boosted DR4 and DR5 mRNA expression in TNBC cells.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 12
December 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
JASMINE M. MANOUCHEHRI, MICHAEL KALAFATIS
Anticancer Research Dec 2018, 38 (12) 6789-6795; DOI: 10.21873/anticanres.13050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
JASMINE M. MANOUCHEHRI, MICHAEL KALAFATIS
Anticancer Research Dec 2018, 38 (12) 6789-6795; DOI: 10.21873/anticanres.13050
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of RATS Lobectomy and VATS Lobectomy for Early-stage Non-small Cell Lung Cancer
  • Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study
  • Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer
Show more Clinical Studies

Keywords

  • apoptosis
  • Breast cancer
  • c-FLIPL
  • death receptors
  • ursolic acid
  • rhTRAIL
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire